Event Details
- Event Type: Earnings conference call for analysts and investors
- Purpose: Discussion of Unaudited Financial Results (Standalone and Consolidated) for quarter ended June 30, 2026
- Date: Thursday, August 13, 2026
- Time: 04:30 PM (IST)
Management Participants
- Mr. Mark Saldanha – Founder, Chairman and Managing Director
- Mr. Jitendra Sharma – Chief Financial Officer
Call Arrangements
Organized by: DAM Capital Advisors Ltd
Call Leader: Nitin Agarwal – Analyst, DAM Capital Advisors Ltd
Dial-in Details:
- Universal access: +91 22 6280 1384, +91 22 7115 8285 (accessible from all networks and countries)
- Diamond passcode link provided for registration
International Toll-Free Numbers:
- Hong Kong: 800964448 (19:00 HKT)
- Singapore: 8001012045 (19:00 SGT)
- UK: 08081011573 (12:00 PM BST)
- USA: 18667462133 (07:00 EDT)
Post-Call Availability
The presentation along with the audio recording of the call and the transcript will be hosted on the Company's website at https://www.marksanspharma.com/earnings-call-transcripts.html
Filing Details
Digital Signature Timestamp: 2026.08.03 18:25:33 +05'30'